PCV9 CARDIOVASCULAR EVENT REDUCTION AFTER TREATMENT WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS GENERIC SIMVASTATIN THERAPY FROM A MANAGED CARE ORGANIZATIONS PERSPECTIVE IN THE UNITED STATES

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74536-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74536-8/fulltext
Title : PCV9 CARDIOVASCULAR EVENT REDUCTION AFTER TREATMENT WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS GENERIC SIMVASTATIN THERAPY FROM A MANAGED CARE ORGANIZATIONS PERSPECTIVE IN THE UNITED STATES
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74536-8&doi=10.1016/S1098-3015(10)74536-8
First page :
Section Title :
Open access? : No
Section Order : 464
Categories :
Tags :
Regions :
ViH Article Tags :